Faculty Associate Gerard Anderson explains the role of Pharmacy Benefits Managers and whether they are to blame for the rising costs of prescriptions, as pharmaceutical companies and politicians are claiming.
News Archive
Should the U.S. save Medicare money by pegging drug prices to what other countries pay?
If the U.S. wants a better deal on some medicines, the federal government could try pegging prices to what is paid by Japan, the U.K., and the Canadian province of […]
Hospitals Chafe Under A Medicare Rule That Reduces Payments To Far-Flung Clinics
Over the past decade, hospitals have been rapidly building outpatient clinics or purchasing existing independent ones. It was a lucrative business strategy because such clinics could charge higher rates, on […]
Invisible Middlemen Are Slowing Down American Health Care
Nurses spend 16 hours on the phone, medications take months to arrive, and patients suffer as they wait. Faculty Associate Gerard Anderson is quoted.
Gov. Tony Evers Wants prescription drug companies and other entities to disclose information on prices
Like most prices in health care, what health plans pay for prescription drugs is cloaked in secrecy. Governor Tony Evers wants those prices to be at least a bit less […]
Is Medical Pot a Blessing for Seniors?
In states that legalized medical marijuana, there was a 4.8 percent decrease in reported pain for conditions that qualified for pot treatment (cancer, arthritis, glaucoma and pain), compared to states […]
Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
The new strategy of some health plans for state employees is to pay hospitals a certain percentage above the basic Medicare reimbursement rate. It allows hospitals a small profit, the […]
Editorial: High drug prices just one example of special interests thwarting popular will
[Opinion]Research and development accounts for only about 17 percent of total spending at most big pharma companies. Faculty Associate Gerard Anderson is quoted.
How To End The Scourge Of Surprise Medical Bills In The Emergency Room
Opponents of the role of consumers and markets in health care have one go-to argument above all others: that you can’t shop for health care when you’re unconscious. The rising […]
Two Maryland bills are the state’s latest attempt to rein in drug prices
Even as Congress holds hearings and the White House proposes updating rules for drug pricing, Maryland and some other states are also searching for ways to make prescription medications more […]